# Biotech Daily Digest — 2026-02-21

**5 items from 2 sources**

## Summary by Source

- Endpoints News: 3 items
- Fierce Biotech: 2 items


## Endpoints News

- **[Potential Eylea competitor disappoints; FDA to review Moderna’s flu vaccine; Another rare disease rejection; and more](https://endpoints.news/potential-eylea-competitor-disappoints-fda-to-review-modernas-flu-vaccine-another-rare-disease-rejection-and-more/)**  
  _Sat, 21 Feb 2026 11:00:24 +0000_  
  Welcome back to another edition of Endpoints Weekly! For those that had time off for Presidents’ Week, we hope you had a restful vacation. If you missed any of the headlines, we had a lot ...

- **[Vanda gets FDA approval for ‘franchise-extending’ antipsychotic](https://endpoints.news/vanda-gets-fda-approval-for-franchise-extending-antipsychotic/)**  
  _Sat, 21 Feb 2026 00:51:50 +0000_  
  The FDA approved Vanda Pharmaceuticals’ drug Bysanti for schizophrenia and for the acute treatment of manic or mixed episodes related to bipolar I disorder.

 Bysanti is an active metabolite of Vanda’s currently approved atypical antipsychotic ...

- **[Grail's cancer test faces new uncertainty after UK study](https://endpoints.news/grails-cancer-test-faces-new-uncertainty-after-uk-study/)**  
  _Fri, 20 Feb 2026 20:09:44 +0000_  
  After mounting a comeback with fresh capital and a flashy partnership, Grail once again faces major questions over the future of its blood test that screens for dozens of cancers.

 The company's test, called Galleri ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/pharma/supreme-court-steps-trumps-tariffs-thrown-out" hreflang="en">Supreme Court steps in: Trump's emergency tariffs struck down</a>](https://www.fiercebiotech.com/pharma/supreme-court-steps-trumps-tariffs-thrown-out)**  
  _Feb 20, 2026 10:26am_  
  After the pharmaceutical industry spent much of the past year safeguarding its businesses against the threat of U.S. import tariffs, a new Supreme Court ruling now waylays the Trump administration's trade agenda—at least in part.

- **[<a href="https://www.fiercebiotech.com/biotech/white-house-frustration-may-have-fueled-fdas-moderna-change-politico" hreflang="en">White House frustration fueled FDA’s Moderna walkback: reports</a>](https://www.fiercebiotech.com/biotech/white-house-frustration-may-have-fueled-fdas-moderna-change-politico)**  
  _Feb 19, 2026 11:33am_  
  Politico has reported that the White House isn’t happy with the FDA’s recent actions surrounding vaccines, fueling public scrutiny of internal decision-making at the regulator.
